Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024

BUY
$0.42 - $0.72 $189 - $324
450 Added 3.94%
11,872 $7,000
Q3 2023

Nov 02, 2023

SELL
$0.6 - $1.53 $8,154 - $20,792
-13,590 Reduced 54.33%
11,422 $6,000
Q2 2023

Aug 09, 2023

BUY
$1.05 - $1.63 $13,996 - $21,727
13,330 Added 114.11%
25,012 $28,000
Q1 2023

May 10, 2023

SELL
$1.2 - $2.73 $480 - $1,092
-400 Reduced 3.31%
11,682 $15,000
Q4 2022

Jan 18, 2023

SELL
$1.71 - $3.61 $11,393 - $24,053
-6,663 Reduced 35.55%
12,082 $0
Q3 2022

Oct 14, 2022

SELL
$1.9 - $8.63 $21,812 - $99,072
-11,480 Reduced 37.98%
18,745 $46,000
Q2 2022

Jul 13, 2022

SELL
$2.13 - $9.01 $4,381 - $18,533
-2,057 Reduced 6.37%
30,225 $74,000
Q1 2022

May 12, 2022

BUY
$6.28 - $15.59 $17,866 - $44,353
2,845 Added 9.66%
32,282 $258,000
Q4 2021

Feb 10, 2022

SELL
$14.7 - $28.67 $194,289 - $378,931
-13,217 Reduced 30.99%
29,437 $450,000
Q3 2021

Oct 14, 2021

BUY
$24.31 - $33.6 $302,173 - $417,648
12,430 Added 41.13%
42,654 $1.21 Million
Q2 2021

Aug 12, 2021

SELL
$26.09 - $40.4 $80,252 - $124,270
-3,076 Reduced 9.24%
30,224 $1.02 Million
Q1 2021

Apr 22, 2021

BUY
$33.06 - $56.93 $255,256 - $439,556
7,721 Added 30.18%
33,300 $1.27 Million
Q4 2020

Apr 01, 2021

BUY
$39.09 - $57.4 $289,266 - $424,760
7,400 Added 40.71%
25,579 $1.07 Million
Q3 2020

Nov 02, 2020

SELL
$28.43 - $44.67 $77,358 - $121,547
-2,721 Reduced 13.02%
18,179 $788,000
Q2 2020

Aug 17, 2020

BUY
$11.71 - $30.29 $38,760 - $100,259
3,310 Added 18.82%
20,900 $633,000
Q1 2020

May 12, 2020

SELL
$7.64 - $27.5 $87,294 - $314,215
-11,426 Reduced 39.38%
17,590 $240,000
Q4 2019

Feb 10, 2020

SELL
$15.02 - $20.57 $43,558 - $59,653
-2,900 Reduced 9.09%
29,016 $468,000
Q3 2019

Nov 13, 2019

BUY
$18.85 - $27.5 $148,085 - $216,040
7,856 Added 32.65%
31,916 $615,000
Q2 2019

Aug 14, 2019

BUY
$17.37 - $26.27 $226,417 - $342,429
13,035 Added 118.23%
24,060 $565,000
Q1 2019

May 13, 2019

BUY
$10.65 - $25.75 $117,416 - $283,893
11,025 New
11,025 $258,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Private Advisor Group, LLC Portfolio

Follow Private Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.